clinical trial · NCT06100952
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus
KeratoconusRiboflavin and Sodium Iodide solution and Ultraviolet-A treatmentPlacebo and sham treatment
brief summary
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
started
Nov 1, 2023
primary completion
Nov 1, 2025
completion
Nov 1, 2025
last updated
Feb 20, 2025
official title
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus (APRICITY-B)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol